About Uterine Fibroids / MyomaUterine fibroids (also referred to as uterine myomas, leiomyoma, leiomyomata, and fibromyoma) are benign (non-cancerous) tumors that grow within the muscle tissue of the uterus. Between 20-50% of women of childbearing age have uterine fibroids. While many women do not experience any problems, symptoms can be severe enough to require treatment. More
Uterine Fibroid Symptoms: Weight Gain‚ Bleeding‚ Pressure and PainMany women who have uterine fibroids have no symptoms and never require treatment. However, one out of four women of childbearing age does suffer from significant symptoms. Uterine fibroid symptoms may vary depending on the location, size and number of fibroids. Do you suffer from these symptoms? More
Effects of HysterectomyIn the USA, approximately 600,000 operations are carried out annually, and almost one-third of women have had a hysterectomy by the age of 60 years. Approximately 90% of hysterectomies are performed on benign indications to improve quality of life and the most common indication for surgery is uterine fibroids. More
How focused ultrasound destroys fibroids with an intact uterusA combination of 2 technologies: High intensity focused ultrasound to heat and destroy targeted tissue and Magnetic resonance imaging (MRI) for precise visualization, guidance and real time treatment control More
Why choose treatment with focused ultrasound?
- Preserves the uterus
- Is non-invasive - so there's no cutting, no scars or general anesthesia
- Is an outpatient procedure - there's no hospital stay
- Is a safe procedure and because it is non-invasive, there is less risk of infections
- There's a short recovery time - you'll return to livelihood quickly
Your guide to understand the insurance process in the USAIf you have been denied insurance coverage for focused ultrasound in the USA
please call 1-866-392-2528.
Navigating the health insurance process can be confusing. This page is aimed to help patients seek coverage and payment for Focused Ultrasound Surgery (also known as MRgFUS) for the treatment of their uterine fibroids.